Hutto, Spencer K. https://orcid.org/0000-0002-5644-9638
Balaban, Denis
Rohm, Zachery
Lackey, Elijah
Samudralwar, Rohini D.
El Sammak, Sally
Nakirikanti, Anudeep
Oyerinde, Esther
Bou, Gabriela
Herman, Max
Horta, Lucas
Taha, Mohamed
Rivera Torres, Noellie
Morrison, Andrew
Shah, Suma
Pawate, Siddharama
Vargas, Diana
Tyor, William
Article History
Received: 1 May 2025
Revised: 4 June 2025
Accepted: 8 June 2025
First Online: 18 July 2025
Declarations
:
: S. K. Hutto reports no disclosures; D. T. Balaban reports that his institution receives support from ArgenX for an investigator-initiated clinical trial; Z. Rohm reports no disclosures; E. Lackey reports no disclosures; R. D. Samudralwar reports no disclosures; S. El Sammak reports no disclosures; A. Nakirikanti reports no disclosures; E. Oyerinde reports no disclosures; G. Bou reports no disclosures; M. Herman reports no disclosures; L. Horta reports no disclosures; M. Taha reports no disclosures; N. Rivera Torres reports no disclosures; A. Morrison reports no disclosures; S. Shah has received honoraria from Novartis and TGTherapeutics for participation in advisory boards and consulting, respectively; S. Pawate reports no disclosures; D. Vargas reports no disclosures; W. Tyor reports no disclosures.
: This study was performed in line with the principles of the Declaration of Helsinki. Utilizing a shared study protocol, local institutional review boards for each participating center approved this retrospective study with complete waivers of consent granted in view of its retrospective nature and all procedures being previously performed as a manner of routine care. Upon request by qualified investigators, anonymized data will be made available as subject to ethics board approval.